| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NVTA | Exit | InVitae Corporation | $0 | – | -1,276,541 | -100.0% | -2.19% | – |
| Exit | Erasca, Inc. | $0 | – | -2,500,000 | -100.0% | -13.59% | – | |
| NAUT | Exit | Nautilus Biotechnology, Inc. | $0 | – | -16,298,006 | -100.0% | -24.08% | – |
| Exit | EQRx, Inc. | $0 | – | -17,438,465 | -100.0% | -60.15% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EQRx, Inc. | 4 | Q3 2022 | 61.9% |
| Nautilus Biotechnology, Inc. | 4 | Q3 2022 | 40.8% |
| Erasca, Inc. | 4 | Q3 2022 | 20.3% |
| InVitae Corporation | 4 | Q3 2022 | 9.3% |
View AH Equity Partners Bio II, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-11-09 |
| 4 | 2023-01-04 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 3 | 2021-12-22 |
| 3 | 2021-06-09 |
View AH Equity Partners Bio II, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.